Symbols

XCUR

Exicure·NASDAQ

--(--)

Signals Analysis

Bullish signal 0

Bearish signal 2

Price Hits New Low

Price Hits 52-week Low

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About XCUR

Exicure, Inc.

An early-stage biotechnology company that developing nucleic acid therapies targeting RNA to address neurological disorders and hair loss disorders

Industry

Pharmaceutical

Established Date

07/09/2015

Listing Date

07/31/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.exicuretx.com

Security Type

Common stock

Office address

400 Seaport Court Suite 102 Redwood City CA 94063

Business

Introduction

Exicure, Inc., was founded on July 9, 2015. The company is focusing on exploring strategic alternatives after suspending its historical biotechnology R&D activities. It has acquired GPCR Therapeutics USA, which completed a Phase 2 clinical trial in blood cancer patients, and the company is managing related licensing and development obligations.

Company Financials

EPS

XCUR has released its 2025 Q3 earnings. EPS was reported at -0.39, versus the expected 0, missing expectations. The chart below visualizes how XCUR has performed over recent quarters, highlighting trends in earnings surprises.